Parallax Volatility Advisers, L.P. Aurinia Pharmaceuticals Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.32 - $7.33 $52,668 - $72,567
-9,900 Reduced 49.25%
10,200 $74,000
Q2 2024

Aug 14, 2024
SELL
$4.81 - $5.78 $403,077 - $484,364
-83,800 Reduced 80.65%
20,100 $114,000
Q1 2024

May 15, 2024
BUY
$4.93 - $9.31 $231,710 - $437,570
47,000 Added 82.6%
103,900 $520,000
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $325,841 - $433,693
45,700 Added 408.04%
56,900 $511,000
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $83,139 - $131,289
10,700 Added 2140.0%
11,200 $87,000
Q2 2023

Aug 14, 2023
SELL
$8.96 - $11.69 $292,992 - $382,263
-32,700 Reduced 98.49%
500 $4,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $44,550 - $84,525
7,500 Added 29.18%
33,200 $363,000
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $411 - $814
100 Added 0.39%
25,700 $111,000
Q3 2022

Nov 14, 2022
BUY
$6.66 - $12.39 $170,496 - $317,184
25,600 New
25,600 $192,000
Q1 2022

May 16, 2022
SELL
$10.05 - $22.48 $400,995 - $896,952
-39,900 Reduced 99.01%
400 $5,000
Q4 2021

Feb 14, 2022
SELL
$17.78 - $33.08 $421,386 - $783,996
-23,700 Reduced 37.03%
40,300 $922,000
Q3 2021

Nov 15, 2021
BUY
$10.93 - $23.55 $699,520 - $1.51 Million
64,000 New
64,000 $1.42 Million

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.29B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email